Immune mechanisms involved in cardiovascular complications of chronic kidney disease. [electronic resource]
Producer: 20100429Description: 114-20 p. digitalISSN:- 1421-9735
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Animals
- Anti-Inflammatory Agents -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Antioxidants -- therapeutic use
- Atherosclerosis -- etiology
- Cardiomyopathies -- etiology
- Cardiovascular Diseases -- etiology
- Chronic Disease
- Clinical Trials as Topic
- Endothelium, Vascular -- physiopathology
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Inflammation -- drug therapy
- Interleukin-6 -- metabolism
- Kidney Diseases -- complications
- Membranes, Artificial
- Mice
- Periodontitis -- complications
- Renal Dialysis -- adverse effects
- Tumor Necrosis Factor-alpha -- metabolism
- Vasculitis -- etiology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.